Lineage Cell Therapeutics, Inc. (LCTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.76
Day's range
$1.86

Lineage Cell Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BROADWOOD CAPITAL INC 05/15/2026 49.56 M $78.31 M   0.00% 21.54%
05/15/2026 8.32 M $13.14 M   100.00% 3.62%
DEFENDER CAPITAL, LLC. 04/13/2026 6.73 M $10.63 M   -1.46% 2.92%
MILLENNIUM MANAGEMENT LLC 05/15/2026 5.56 M $8.79 M   163.52% 2.42%
RAFFLES ASSOCIATES LP 05/15/2026 5.36 M $8.47 M   0.00% 2.33%
FIFTH THIRD BANCORP 05/01/2026 4.60 M $7.27 M   100.00% 2.00%
BLACKROCK, INC. 05/13/2026 3.86 M $6.11 M   0.80% 1.68%
ARMISTICE CAPITAL, LLC 05/15/2026 3.18 M $5.03 M   100.00% 1.38%
MARSHALL WACE, LLP 05/15/2026 3.07 M $4.84 M   125.03% 1.33%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.52 M $3.99 M   2.52% 1.10%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 2.13 M $3.36 M   -11.63% 0.92%
MORGAN STANLEY 05/15/2026 1.87 M $2.95 M   -6.51% 0.81%
UBS GROUP AG 05/05/2026 1.37 M $2.17 M   648.37% 0.60%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 1.32 M $2.09 M   100.00% 0.58%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 1.30 M $2.06 M   84.69% 0.57%
GOLDMAN SACHS GROUP INC 05/15/2026 1.17 M $1.85 M   -18.72% 0.51%
STATE STREET CORP 05/15/2026 1.09 M $1.72 M   7.27% 0.47%
JANE STREET GROUP, LLC 05/12/2026 993.21 K $1.57 M   -1.15% 0.43%
RED CRANE WEALTH MANAGEMENT, LLC 04/29/2026 597.26 K $943.68 K   0.00% 0.26%
NORTHERN TRUST CORP 05/14/2026 499.13 K $788.62 K   4.14% 0.22%
SEI INVESTMENTS CO 05/13/2026 422.27 K $667.20 K   56.80% 0.18%
BANK OF AMERICA CORP /DE/ 05/18/2026 419.36 K $662.58 K   111.96% 0.18%
BARCLAYS PLC 05/15/2026 393.31 K $621.43 K   12.85% 0.17%
EAM INVESTORS, LLC 05/13/2026 346.62 K $547.65 K   -21.62% 0.15%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 304.36 K $480.89 K   90.93% 0.13%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 259.56 K $410.11 K   22.81% 0.11%
HRT FINANCIAL LP 05/14/2026 232.26 K $366.00 K   100.00% 0.10%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 221.00 K $349.18 K   0.00% 0.10%
04/23/2026 216.00 K $341.28 K   0.00% 0.09%
FMR LLC 05/15/2026 193.31 K $305.43 K   0.70% 0.08%
BREVAN HOWARD CAPITAL MANAGEMENT LP 05/15/2026 186.79 K $295.14 K   100.00% 0.08%
GSA CAPITAL PARTNERS LLP 05/08/2026 185.06 K $292.00 K   -44.09% 0.08%
CITIGROUP INC 05/11/2026 175.08 K $276.62 K   147.50% 0.08%
CATALYST FUNDS MANAGEMENT PTY LTD 05/11/2026 170.30 K $269.07 K   172.92% 0.07%
SQUAREPOINT OPS LLC 05/15/2026 143.19 K $226.24 K   119.92% 0.06%
CITADEL ADVISORS LLC 05/15/2026 130.95 K $206.90 K   -74.17% 0.06%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 129.92 K $205.28 K   0.01% 0.06%
JAIN GLOBAL LLC 05/15/2026 122.05 K $192.84 K   214.15% 0.05%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 111.29 K $175.83 K   49.48% 0.05%
OMERS ADMINISTRATION CORP 05/15/2026 109.00 K $172.22 K   -61.51% 0.05%
COMMONWEALTH EQUITY SERVICES, LLC 04/27/2026 102.83 K $162.47 K   -1.38% 0.04%
WILLIAMS JONES WEALTH MANAGEMENT, LLC. 05/05/2026 101.30 K $160.05 K   0.00% 0.04%
HIGHTOWER ADVISORS, LLC 05/05/2026 99.87 K $157.80 K   1.52% 0.04%
TWO SIGMA INVESTMENTS, LP 05/15/2026 88.59 K $139.96 K   -66.65% 0.04%
VANGUARD GLOBAL ADVISERS, LLC 05/08/2026 85.80 K $135.56 K   100.00% 0.04%
VOLEON CAPITAL MANAGEMENT LP 05/15/2026 85.74 K $135.47 K   20.81% 0.04%
RAYMOND JAMES FINANCIAL INC 05/14/2026 83.98 K $132.70 K   4.74% 0.04%
TRUST CO OF TOLEDO NA /OH/ 04/15/2026 83.80 K $132.40 K   147.95% 0.04%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 79.80 K $126.08 K   56.16% 0.03%
VIRTU FINANCIAL LLC 05/14/2026 63.81 K $101.00 K   100.00% 0.03%

Lineage Cell Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 170 institutional investors and hedge funds held shares of Lineage Cell Therapeutics Inc. The most heavily invested institutionals were:

BROADWOOD CAPITAL INC: 49.56 M

Defender Capital, LLC.: 6.73 M

MILLENNIUM MANAGEMENT LLC: 5.56 M

RAFFLES ASSOCIATES LP: 5.36 M

FIFTH THIRD BANCORP: 4.6 M

BlackRock, Inc.: 3.86 M

48.54% of Lineage Cell Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 128.10 M shares in the last 24 months. This purchase volume represents approximately $225.45 M in transactions.